Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May 10;13(5):1101.
doi: 10.3390/microorganisms13051101.

Exploring the Gut Microbiota-Retina Axis: Implications for Health and Disease

Affiliations
Review

Exploring the Gut Microbiota-Retina Axis: Implications for Health and Disease

Nicola Schiavone et al. Microorganisms. .

Abstract

The gut microbiota represents a rich and adaptive microbial network inhabiting the gastrointestinal tract, performing key functions in nutrient processing, immune response modulation, intestinal wall protection, and microbial defense. Its composition remains highly personalized and responsive to external influences, including lifestyle patterns, physical activity, body composition, and nutritional intake. The interactions of the gut microbiota with bodily systems are conventionally interpreted as broad systemic impacts on organ balance. Yet, emerging research-exemplified by the gut microbiota-brain axis-suggests the potential existence of more targeted and direct communication mechanisms. Dysbiosis, characterized by microbial ecosystem disturbance, generates multiple metabolic compounds capable of entering systemic circulation and reaching distant tissues, notably including ocular structures. This microbial imbalance has been associated with both systemic and localized conditions linked to eye disorders. Accumulating scientific evidence now supports the concept of a gut-retina axis, underscoring the significant role of microbiota disruption in generating various retinal pathologies. This review comprehensively investigates gut microbiota composition, functional dynamics, and dysbiosis-induced alterations, with specific focus on retinal interactions in age-related macular degeneration, diabetic retinopathy, glaucoma, and retinal artery occlusion. Moreover, the review explores microbiota-targeted therapeutic strategies, including precision nutritional interventions and microbial transplantation, as potential modulators of retinal disease progression.

Keywords: AMD; diabetic retinopathy; dietary interventions; fecal transplantation; glaucoma; non-coding RNAs; postbiotic; prebiotic; probiotic; retinal artery occlusion.

PubMed Disclaimer

Conflict of interest statement

Author C.V.D.A. has been involved as a consultant with Press Star SRL Società Benefit, Italy. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Bidirectional crosstalk between the gut and the microbiota, which occurs through intricate communication mediated by various metabolites, informational molecules, and cargo transport systems, such as extracellular vesicles (created with BioRender.com, https://app.biorender.com/, accessed on 27 March 2025).
Figure 2
Figure 2
The gut microbiota–retina axis. The gut microbiota plays a regulatory role in retinal homeostasis. Numerous stressors—such as nutritional imbalances, drugs, aging, psychological and physical stress—can lead to dysregulation in both the composition and function of the gut microbiota. The resulting dysbiosis can disrupt crosstalk with the retina, influencing the pathogenesis of various retinal diseases through multiple mechanisms, including alteration in gut cell trophism, changes in microbial metabolite production, modulation of immune responses, the establishment of low-grade chronic inflammation, disruption of gut barrier integrity, and translocation of microbes/microbial products to the retina (created with BioRender.com, https://app.biorender.com/, accessed on 27 March 2025).

References

    1. Santoro A., Zhao J., Wu L., Carru C., Biagi E., Franceschi C. Microbiomes Other than the Gut: Inflammaging and Age-Related Diseases. Semin. Immunopathol. 2020;42:589–605. doi: 10.1007/s00281-020-00814-z. - DOI - PMC - PubMed
    1. Franceschi C., Garagnani P., Parini P., Giuliani C., Santoro A. Inflammaging: A New Immune-Metabolic Viewpoint for Age-Related Diseases. Nat. Rev. Endocrinol. 2018;14:576–590. doi: 10.1038/s41574-018-0059-4. - DOI - PubMed
    1. Bischoff S.C. Microbiota and Aging. Curr. Opin. Clin. Nutr. Metab. Care. 2016;19:26–30. doi: 10.1097/MCO.0000000000000242. - DOI - PubMed
    1. Chaudhry T.S., Senapati S.G., Gadam S., Mannam H.P.S.S., Voruganti H.V., Abbasi Z., Abhinav T., Challa A.B., Pallipamu N., Bheemisetty N., et al. The Impact of Microbiota on the Gut-Brain Axis: Examining the Complex Interplay and Implications. J. Clin. Med. 2023;12:5231. doi: 10.3390/jcm12165231. - DOI - PMC - PubMed
    1. Zeng H., Chi H. Metabolic Control of Regulatory T Cell Development and Function. Trends Immunol. 2015;36:3–12. doi: 10.1016/j.it.2014.08.003. - DOI - PMC - PubMed

LinkOut - more resources